Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients

Early treatment of CLL/SLL does not impact survival-reflecting limitations in detecting progression early and identifying asymptomatic patients likely to benefit from early treatment. Improved understanding of CLL/SLL biology would identify better prognostic/predictive markers. This study attempts t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Karmali, Reem, Paganessi, Laura A., Frank, Robin R., Jagan, Sucheta, Larson, Melissa L., Venugopal, Parameswaran, Gregory, Stephanie A., Christopherson, Kent W.
Format: Artigo
Idioma:Inglês
Publicat: Society for Leukocyte Biology 2013
Matèries:
Translational & Clinical Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3525834/
https://ncbi.nlm.nih.gov/pubmed/23136257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.0612301
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars